期刊文献+

URC测试对消化道恶性肿瘤根治术后复发监测的临意义 被引量:4

The clinical research on URC test for the relapse after the digestive tract cancer radical operation
下载PDF
导出
摘要 目的:探讨癌症尿液筛查监测试剂(URC)测试对消化道恶性肿瘤术后复发监测诊断的临床意义。方法:对100例消化道恶性肿瘤根治术后病人每月一次URC测试,与实际复发情况,进行阳性符合率、阴性符合率、灵敏度、假阳性率统计分析。结果:两家医院2年内100例患者共测480次,阳性146次(30.4%),阴性334例次(69.6%),其中真阳性124次(25.8%),真阴性310次(64.6%),阳性符合率84.9%,阴性符合率92.8%。,灵敏度83.8%,假阳性率(误诊率)6.6%。结论:URC测试对消化道恶性肿瘤根治术后复发监测有临床实用意义,能对复发早诊断提供线索,灵敏度高、误诊率低,无创简便易行,值得临床进一步研究推广。 Objective:To explore the URC test for monitoring the relapses after digestive tract cancer radiacal operation . Methods: Total of 100 Digestive tract cancer patients with radical operation were tested with URC once monthly, to analyse positive coincidence rate negative coincidence rate sensitivity and mistake diagnostic rate. Resuits: There were 480 times totally to 100 pateints tested by URC in two years , the positive case is 146 times (30.4%), the negative case is 334 times(69.6% ), true positive 124 times(25.8% ), true negative 310 times ( 64.6% ), the positive coincidence rate was 84.9%, the negative coincidence rate 92.8% , sensitivity was 83.8%, false positive rate( misdiagnosis rate) 6.6%. Conclusion: URC test after radical operation can early provide the clues to relapse of digestive tract cancer,its sensitivity is high, the misdiagnosis rate is low, no wound, simple and easy handling.
出处 《现代肿瘤医学》 CAS 2006年第12期1581-1582,共2页 Journal of Modern Oncology
关键词 URC测试 消化道恶性肿瘤 术后复发监测 URC test digestive tract cancer relapse monitoring after operation
  • 相关文献

参考文献6

二级参考文献40

  • 1万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 2李立明.流行病学:第4版[M].北京:人民卫生出版社,2002.50.
  • 3Kim DY, Kim HR, Shim JH, et al. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients [J]. J Surg Oncol, 2000,74 (3): 185-192.
  • 4Duraker N, Celik AN. The prognostic significance of preoperative serum CA19-9 in patients with respectable gastric carcinoma: comparison with CEA[J]. J Surg Oncol, 2001,76(4):266-271.
  • 5Marrelli D, Pinto E, De Stefano A, et al. Preoperative positivity of serum tumor markers in a strong predictor of hematogenous recurrence of gastric cancer [J]. J Surg Oncol, 2001,78(4):253-258.
  • 6Bando E, Yonemura Y, Tabesbita Y, et al. Intraoperative lavage for cytological examination in 1 297 patients with gastric carcinoma [J]. Am J Surg, 1999,178(3) :256--262.
  • 7Nakata B, Hirakawa YS, Chung K, et al. Serum CA125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma [J]. Cancer, 1998,83(12):2488-2492.
  • 8Pectasides D, Mylonalakis A, Kostopoulou M, et al.CEA, CA19-9, and CA-50 in monitoring gastric carcinoma [J]. Am J Clin Oncol, 1997,20(4): 348-353.
  • 9Nakata B, Chung K, Muguruma K, et al. Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma [J].Cancer, 1998,83(1) : 19-24.
  • 10Gaspar MJ Arribas I, Coca MC, et al. Prognostic value of carcinoembryonic antigen, CA19-9 and CA72-4 in gastric carcinoma [J]. Tumor Biol, 2001,22(5):318--322.

共引文献29

同被引文献42

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部